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Glucose oxidation after a peritoneal and an oral glucose load In dialyzed
patients. Glucose oxidation and thermogenesis were studied after a
peritoneal (P) and an oral (0) glucose load in nine chronically uremic
patients undergoing continuous ambulatory peritoneal dialysis (CAPD)
for 24.4 5.8 months. The 0 load (50 g) given was equivalent to the
amount of glucose absorbed over six hours through the peritoneum of
the subjects (51.7 3.3 g). Glucose oxidation and energy expenditure
were obtained using indirect calorimetry in basal state and over the six
hours following the glucose load. Glucose oxidation rate was higher
from 60 to 180 minutes after 0 than after P (P < 0.05), with peak values
of 3.85 0.28mg kg' min' and 2.80 0.17 mg kg . miir1
respectively (P < 0.05). Cumulated glucose oxidation over six hours
was 53.6 0.6 versus 47.0 3.4 g after 0 and P respectively (NS).
Glucose-induced thermogenesis was 8.7 2.9% versus 5 1.9% after
O and P, respectively (NS). The route of administration of glucose
induces different kinetics of the glucose oxidation rate, but a similar
amount of glucose absorbed either by the peritoneum or by the gut
contributes in a similar extent to glucose and energy balance.
Continuous ambulatory peritoneal dialysis (CAPD) is a
chronic renal replacement therapy in patients with end-stage
renal disease [1]. This technique is based on the exchanges
between the blood and a peritoneal solution which is replaced
many times a day through an implanted catheter. In this
solution, glucose is used as the osmotic agent because of its low
metabolic toxicity compared to other osmotic molecules [2].
Most of the glucose present in the dialysis solution is absorbed
through the peritoneum [3] and contributes to glucose and to
energy metabolism. The amount of glucose absorbed through
the peritoneum is thought to have beneficial effects on the
energy balance. It compensates for the low energy intake
secondary to the anorexia frequently observed in CAPD pa-
tients [4]. The contribution of glucose to oxidative and energy
metabolism after intraperitoneal administration may differ from
that observed after oral administration because of different
glycemic and insulinemic responses [5] and because the gut—
which is by-passed when glucose is instilled in the peritone-
um.—plays a specific role in the metabolic response to an oral
glucose load [6]. The aim of the present study was to compare
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the oxidative metabolism and the thermogenic response in-
duced by similar peritoneal and oral glucose load in CAPD
patients.
Methods
Patients
Nine clinically stable, non-diabetic, chronically uremic pa-
tients (4 women and 5 men; 69.4 11.7 years old; 61.1 9.9 kg,
Body Mass Index: 22.9 3.5 kg/m2) gave their written consent
for the participation to the study. Three patients were anuric.
All the patients underwent CAPD for at least six months (9 to 55
months). None had suffered from peritonitis for at least six
months. The clinical characteristics of the patients are pre-
sented in Table 1. The protocol was approved by the Ethical
Committee of our institution.
The patients were studied twice, one to three weeks apart. In
study I, glucose was given in peritoneum cavity; in study II,
glucose was given orally. Study I was initially performed in all
patients because it was necessary to determine the amount of
glucose absorbed through the peritoneum. The patients' usual
carbohydrate intake was at least 250 g a day including the
estimated amount of glucose brought by the dialysis solutions
(estimated to be 60% of glucose present in dialysis solutions).
The patients were instructed to eat a standardized meal and to
drain any dialysate from peritoneum 12 hours before each
study. All studies were conducted as follows: patients were
admitted after 12 hours fast in our Metabolic Unit between
07.00 and 08.00 a.m. They were placed at rest in a bed and
maintained in the supine position throughout the experiments.
A deep forearm vein was cannulated for blood sampling and
was kept open by a saline solution (0.9% NaCI). Their perito-
neal cavity was emptied of any residual dialysate. In study I,
glucose was delivered into the peritoneum within 10 minutes, as
a 2 liter 3.86% anhydrous dextrose solution (sodium lactate:
3.92 g/liter, NaCI: 3.67 g/liter, CaCl: 0.252 g/liter, MgC1: 0.152
gfliter; Baxter, France). Blood samples were sequentially taken
at times —30, 0, 30, 60, 90, 120, 150, 180, 210, 240, 300 and 360
minutes for the determination of glucose, lactate, non-esterified
fatty acids and insulin concentrations. Samples for plasma
bicarbonate and urea level determinations were obtained at
time 0 and time 360 minutes. The intraperitoneal solution was
also sequentially sampled from 30 to 360 minutes for the
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Table 1. Patients characteristics
Patient
no.
Age
years Sex
Weight
kg
BMI
kg/rn2 Primary renal disease
Duration of
CAPD
months
Renal function
mI/mini] .73 m2
1 80 M 46 17.3 Chronic glomerulonephritis 9 5.17
2 66 M 72 23.5 Chronic glomerulonephritis 11 6.39
3 67 M 68 23.8 Chronic interstitial nephritis 15 3.40
4 65 M 71 24.6 Chronic glomerulonephritis 49 0
5 79 F 65 23.9 Chronic pyelonephritis 14 9.38
6 77 F 56 23.0 Chronic glomerulonephritis 55 0
7 59 M 46 17.5 Chronic glomerulonephritis 35 0
8 48 F 60 23.7 Chronic pyelonephritis 11 3.06
9 84 F 66 28,6 Chronic interstitial nephritis 21 0.93
Renal function is determined as creatinine clearance + urea clearance divided by 2.
determination of glucose and urea concentrations. The patients
were weighed at the beginning and at the end of the study. At
the end of the study, the peritoneal cavity was emptied. The
peritoneal glucose load, that is, the difference between the
amount of glucose initially administered and finally recovered
was 51.7 3.3 g. During study II, each patient ingested a 50 g
glucose load diluted in 200 ml water within five minutes.
Analytical procedures
Glycemia was assayed using glucose oxidase method (Beck-
man Glucose Analyzer II). L lactate was assayed enzymatically
(Lactate UV-System, Boehringer Mannheim, Meylan, France).
Non-esterified fatty acid (NEFA) concentrations were deter-
mined by colorimetric method (Biochemica Test Combination,
Boehringer Mannheim). Insulin was measured by radioimmu-
noassay (Phadeseph insulin RIA, Pharmacia Diagnostics AB,
Uppsala, Sweden; normal basal insulin values: 70 to 140 pmoll
liter). Urinary nitrogen was determined by the method of
Kjedahl [7]. Plasma and peritoneal urea was determined by
kinetic UV method on an automatized apparatus (Abbott Spec-
trum, Rungis, France).
Indirect calorimetry
Indirect calorimetry was performed using an open-circuit,
indirect calorimeter with a ventilated hood. Fresh atmospheric
air was continuously drawn into the hood from the outside of
the laboratory building. The flow rate at the outlet was mea-
sured by using a mass flowmeter (Setaram MF 2000-5000,
Caluire, France). Humidity and temperature of the outfiowing
air were measured by a thermometer-hygrometer (HMP 135 Y,
Vaisala, Helsinki, Finland). A fraction of the outfiowing air was
continuously withdrawn by a pump, dried by an electric gas
cooler (CGEK 4, Hartmann & Braun, Metz, France), filtered
for dust, then analyzed for oxygen and carbon dioxide by
differential analyzers (Magnetopneumatic 02 analyzer Magnos
4G and Infrared gas analyzer Uras 3G, Hartmann & Braun),
measuring differential levels of 02 and CO2 between the in- and
the outfiowing air from the hood. The calibration procedure of
the analyzers was conducted as follows: the zero value of each
analyzer was verified by flowing fresh air through the sample
and reference gas lines simultaneously. The gain and the
linearity of the analyzers were checked using mixture of pure
air and N2 or CO2. The mixture was done by an accurate gas
mixing pump (Digamix, WOsthoff Gmbh, Bochum, Germany).
Fresh air 02 concentration was decreased by 0.84 and by 1.88%
with pure N2 and CO2 concentration was increased by 1% and
by 2% with pure CO2.
For data acquisition, analogue voltage outputs of gas analyz-
ers, temperature and humidity probes and of flowmeter were
processed by a computer (Macintosh II, Apple) via an ana-
logue-digital converter (Mac addios, GW mc, Somerville, Mas-
sachusetts, USA). Calculations of V02 and VCO2 were per-
formed by using a scientific software (LabVIEW®, National
Instruments, Austin, Texas, USA). Data acquisition for each
parameter was performed every second and mean calculated
values were displayed every minute. Since the mass flowmeter
was calibrated with fresh air, corrections were introduced
automatically to take into account the changes in water vapor
and in CO2 concentration.
Oxygen consumption (V02) and CO2 production (VCO2)
were calculated using the classical equations, including the
Haldane correction for V02. V02 and VCO2 were measured
during 30 minutes in the basal state after a 30-minute adaptation
period, then continuously until the end of the study. Indirect
calorimetry was performed in eight patients. One of the patients
refused to wear the hood.
Calculations
The amount of glucose found in each dialysis solution was
calculated as the product of the measured glucose concentra-
tion in the solution by the volume of the solution delivered into
the peritoneal cavity. This volume was obtained by weighing
the dialysis bag before and after it was emptied, with the
correction for the density of the solution. The amount of
glucose absorbed through the peritoneum of the subjects (peri-
toneal glucose load) was calculated as the amount of glucose
instilled into the peritoneum minus the amount of glucose
remaining in the dialysate at time 360. The amount of glucose
remaining in the dialysate was calculated as the product of the
measured glucose concentration in dialysate by the volume of
the dialysate recovered from the peritoneal cavity at the end of
the study (obtained by weighing the dialysate bag before and
after it was filled up). It should be stressed that this calculation
is of limited accuracy. Firstly, there was an intra-individual
variation of peritoneal glucose absorption (CV: 10.5%; obtained
in 6 of the 9 subjects). Secondly, it was almost impossible to be
sure that the peritoneal cavity had been completely emptied at
the end of the study. For these practical reasons, the oral
glucose load was set at 50 g for each patient in study II.
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Bicarbonate pooi
Bicarbonate pool was calculated as follows [8]:
HCO3pool = 0.6 x W x sHCO3
where 0.6 is the estimated volume of bicarbonate distribution as
60% of W, W is body weight, sHCO3 is serum HCO3 concen-
tration (mmollliter). The bicarbonate pool did not vary from
time 0 and time 360 after the peritoneal load (824 246 vs. 771
243 mmol, respectively; mean SD) and after the oral load
(879 229 vs. 832 207 mmol, respectively; mean SD).
Therefore no correction was introduced in the calculation of
vC02.
Substrate oxidation
The non-protein respiratory quotient (NPRQ) was deter-
mined from V02 and VCO2 and estimated protein oxidation
rate. Protein oxidation was estimated from nitrogen excretion.
In study I, nitrogen excretion was determined from the excreted
unnary nitrogen and the urea excreted in the dialysate [9]. Total
nitrogen excretion was corrected for variation of body urea pool
[10]. The rate of protein oxidation was assumed to be equal in
study I and study II. Thus, the same rate of protein oxidation
was introduced in the calculation of substrates oxidation for
both studies. Glucose and lipid oxidation were obtained from
NPRQ by using the tables of Lusk [11].
Cumulated glucose balance
The cumulated glucose balance after the peritoneal load was
calculated as the difference in the amount of glucose absorbed
and oxidized over the six hours of the study. During study II,
glucose was assumed to be completely absorbed by the gut over
the six hours [12]. Cumulated nonoxidative glucose disposal
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Fig. 1. Evolution of glucose concentration in dialysate (A), glycemia
(B), insulinemia (C), lactatemia (D) and plasma nonesterfied fatty
acids (E) following peritoneal (0) and oral (•) glucose load. *
0.05, ** P < 0.01 for peritoneal vs. oral load.
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Fig. 2. Evolution of respiratory quotient (A),
glucose oxidation rate (B), lipid oxidation rate
(C) and energy expenditure (D) following
peritoneal (D) and oral (•) glucose load. *
<0.05 for peritoneal vs. oral load.
was calculated by substracting from the glucose load the
amount of glucose oxidized over the six hours and the glycos-
uria.
Glucose-induced thermo genesis
Glucose-induced thermogenesis was calculated as follows:
energy expenditure (kcalmin) during the basal state was sub-
stracted from the mean energy expenditure (kcalmin) over the
six hours following glucose administration, then divided by the
energy content of the glucose load (3.75 kcal/g). Using this
method of calculation, glucose-induced thermogenesis is ex-
pressed as a percentage of the energy content of the glucose
load.
Statistical analysis
Results are expressed as mean SEM and statistical analysis
was performed by a statistical analysis software (Statview Il®,
Casalabas Inc., California, USA). The Mann-Whitney U test or
the Student's unpaired t-test were used where appropriated to
explore the statistical significance of the differerences observed
between the two treatments.
Results
Metabolites and hormone
The kinetics of glucose concentration in dialysate, glycemia,
lactatemia, insulinemia and plasma NEFA are shown in Figure
1. Glucose concentration in dialysate decreased exponentially
as a function of dwell time from 183 5 mri to 42 4 mM (Fig.
1A). Basal glycemia was similar in study I and study 11(5.1
0.3 vs. 4.8 0.3 m, respectively; Fig. lB). Glycemia in-
creased similarly in both studies until 150 minutes, with a peak
value at 60 minutes (9.2 0.6 vs. 9.1 0.6 m study land II,
respectively). Then the decrease was more progressive after the
peritoneal load, glycemia remaining significantly higher (P <
0.05) from 180 to 360 minutes in study II than in study I. Basal
insulinemia was similar in both studies (76 9 vs. 69 8
pmol/liter; study I and II, respectively; Fig. 1C). In study I,
insulinemia peaked at 120 minutes (308 82 pmollliter). In
study II, insulinemia peaked at time 60 minutes (428 41
pmol/liter). Insulinemia was higher from 60 to 90 minutes in
study II than in study I (P < 0.05). During the last three hours
insulinemia was slightly higher in study I than in study II (P <
0.05 at 210 mm). The results obtained for lactatemia are
depicted in Figure 1D. No difference was observed between
study I and study II. The results obtained for NEFA are
depicted in Figure 1E. Basal plasma NEFA were not different
between the two loads (356 50 M and 382 66 sM; study I
and II, respectively). A significant decrease in plasma NEFA
concentration was observed in both studies (P < 0.01). Plasma
NEFA levels increased at the end of both studies but the levels
observed were higher in study II than in study I at 300 and 360
minutes (P < 0.05).
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Respiratory quotient
The mean respiratory quotient (RQ) was similar in both
studies (0.83 0.01 vs. 0.81 0.02; study I and study II,
respectively; Fig. 2A). It was significantly higher in study II
than in study I from 60 to 180 minutes.
Glucose and lipid oxidation
The mean rate of basal glucose oidation was similar in both
studies (1.75 0.16 vs. 1.49 0.35 mg kg" min'; study I
and study II, respectively; Fig. 2B). The rate of glucose
oxidation was significantly higher in study II than in study I
from 60 minutes to 180 minutes (P <0.05).
Cumulated glucose oxidation over the six hours was 47 3.4
and 53.6 3.1 g in study I and study II, respectively (NS) and
amounted for 91% and 107% of the loads, respectively (NS).
Cumulated nonoxidative glucose disposal was 4.01 3.4 g in
study I and —3.6 3.1 g in study II.
The mean rate of basal lipid oxidation was similar in both
studies (1.01 0.16 and 1.10 0.16mg kg min'; study I
and II, respectively; Fig. 2C). The decrease in lipid oxidation
was less pronounced at time 180 minutes (P < 0.05) in study I
than in study II. Cumulated lipid oxidation was 18.2 2.3 g and
17.6 2.2 g, respectively (NS).
Glucose-induced thermo genesis
Basal energy expenditure was similar for both studies (0.89
0.03 and 0.88 0.03 kcal . min1; study I and II, respectively;
Fig. 2D). The energy expenditure increased significantly from 0
to 90 minutes in study II (P < 0.05), but not in study I. The
thermogenic response induced by the glucose load was not
different between the two studies (5 1.9 vs. 8.7 2.9%;
studies I and II, respectively).
Discussion
The exponential decrease in glucose concentration observed
in the dialysate has already been reported [13]. In our CAPD
patients, 73.3 10.5% of the glucose delivered into the perito-
neal cavity was absorbed through the peritoneum. Such a
finding is in accordance with other data [14]. The slower decline
of glycemia observed after the peritoneal load during the last
four hours of the study may be explained by the persistence of
a glucose absorption through the peritoneum. Conversely, all
the glucose is assumed to be completely absorbed within four
hours following an oral load [12]. The higher insulin response
observed between 30 and 120 minutes after the oral load than
after the peritoneal load could be explained by a higher rate of
glucose delivery in plasma and/or to other factors such as the
cephalic phase of insulin release, the enteric release of CCK,
GIP and glucagon like peptides (GLIP) which are bypassed
during pentoneal administration of glucose [6, 15].
As to the plasma NEFA , their lower concentration observed
at the end of the study after the peritoneal load may be related
to the higher insulinemia [16].
Our study shows that the glucose delivered into the perito-
neal cavity via a dialysis solution in CAPD patients is oxidized
and contributes to energy metabolism. Indeed, the amount of
glucose oxidized was similar over the six hour study whatever
its route of administration. These data indicate that the perito-
neal source of glucose must be taken into account when
carbohydrate and energy intakes are considered in CAPD
patients. Although the cumulated glucose oxidation and the
cumulated glucose balance over six hours are similar with the
two routes of glucose administration, the kinetics of the glucose
oxidation rate are very different. The greater rate of glucose
oxidation observed during the first three hours after the oral
load than after the intraperitoneal load may be explained by the
higher insulinemic response inducing a greater rate of glucose
disappearance from plasma and a greater rate of cellular utili-
zation of glucose [17, 18]. The calculation of the rate of glucose
oxidation relies on the estimation of protein oxidation rate from
nitrogen excretion. In the present study, we assumed that the
nitrogen excretion of each patient was identical during the oral
load than during the peritoneal load. Such assumption appeared
to be reasonable for the following reasons: (1) all patients were
clinically and biologically stable; (2) for each patient, the two
studies were performed within one to three weeks; (3) the
evaluation of nitrogen excretion is even more difficult in these
uremic patients than in healthy subjects; (4) each patient acted
as his/her own control in our study. Even though error in the
estimation of the rate of protein oxidation cannot be ruled out,
the kinetics of the RQ which do not depend on the rate of
protein oxidation clearly indicate that the contribution of glu-
cose to energy metabolism was much more pronounced during
the first three hours following the oral load than the peritoneal
load. The rate of glucose oxidation observed after the 50 g oral
glucose load in our patients is similar to what has been observed
after a 50 g oral glucose load in healthy subjects [19].
The basal energy expenditure observed in our CAPD patients
is very close to that reported by Schneeweiss et at [20] in uremic
patients, particularly in chronically uremic patients with con-
servative treatment. The more abrupt increase in energy expen-
diture observed alter the oral glucose load compared to the
peritoneal load may be accounted for by the energy cost of
gastric emptying, glucose digestion and absorption on one hand
[21] and by a greater rate of intracellular metabolism of glucose
on the other hand [17]. There was a 3.7% difference in the
thermogenic response between the two routes of glucose ad-
ministration. The magnitude of this difference is close to the
theorical cost of intestinal absorption [20]. A similar result was
obtained by Vernet et al following enteral versus parenteral
nutrient administration [22].
Our study shows that a similar cumulated glucose oxidation
and glucose balance are obtained alter peritoneal and oral
administration of glucose in CAPD patients. Such a finding
highlights the importance of taking into account the glucose
present in peritoneal dialysis solution when estimating carbo-
hydrate and energy intake in CAPD patients.
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